nodes	percent_of_prediction	percent_of_DWPC	metapath
Torasemide—PTGS1—kidney cancer	0.482	1	CbGaD
Torasemide—CYP2C8—Pazopanib—kidney cancer	0.0499	0.199	CbGbCtD
Torasemide—CYP2C9—Capecitabine—kidney cancer	0.0363	0.145	CbGbCtD
Torasemide—CYP2C8—Erlotinib—kidney cancer	0.0356	0.142	CbGbCtD
Torasemide—CYP2C8—Paclitaxel—kidney cancer	0.0326	0.13	CbGbCtD
Torasemide—SLC12A1—collecting duct of renal tubule—kidney cancer	0.0319	0.382	CbGeAlD
Torasemide—CYP2C8—Sorafenib—kidney cancer	0.029	0.116	CbGbCtD
Torasemide—CYP2C19—Sorafenib—kidney cancer	0.0243	0.0969	CbGbCtD
Torasemide—CYP2C9—Paclitaxel—kidney cancer	0.0228	0.0907	CbGbCtD
Torasemide—CYP2C9—Sorafenib—kidney cancer	0.0202	0.0806	CbGbCtD
Torasemide—SLC12A1—nephron—kidney cancer	0.0142	0.17	CbGeAlD
Torasemide—SLC12A1—urine—kidney cancer	0.0114	0.136	CbGeAlD
Torasemide—CYP2C19—urine—kidney cancer	0.00554	0.0663	CbGeAlD
Torasemide—CYP2C9—urine—kidney cancer	0.0043	0.0514	CbGeAlD
Torasemide—SLC12A1—nephron tubule—kidney cancer	0.00307	0.0367	CbGeAlD
Torasemide—SLC12A1—renal system—kidney cancer	0.00279	0.0333	CbGeAlD
Torasemide—SLC12A1—kidney—kidney cancer	0.00269	0.0322	CbGeAlD
Torasemide—SLC12A1—cortex of kidney—kidney cancer	0.00262	0.0314	CbGeAlD
Torasemide—CYP2C8—renal system—kidney cancer	0.00118	0.0142	CbGeAlD
Torasemide—CYP2C8—kidney—kidney cancer	0.00114	0.0137	CbGeAlD
Torasemide—PTGS1—renal system—kidney cancer	0.00096	0.0115	CbGeAlD
Torasemide—PTGS1—kidney—kidney cancer	0.000928	0.0111	CbGeAlD
Torasemide—PTGS1—cardiac atrium—kidney cancer	0.00086	0.0103	CbGeAlD
Torasemide—Thrombocytopenia—Erlotinib—kidney cancer	0.000377	0.00213	CcSEcCtD
Torasemide—Haemorrhage—Gemcitabine—kidney cancer	0.000376	0.00212	CcSEcCtD
Torasemide—Hyponatraemia—Capecitabine—kidney cancer	0.000375	0.00212	CcSEcCtD
Torasemide—Gastrointestinal haemorrhage—Capecitabine—kidney cancer	0.000374	0.00211	CcSEcCtD
Torasemide—Angioedema—Sunitinib—kidney cancer	0.000373	0.0021	CcSEcCtD
Torasemide—Loss of consciousness—Sorafenib—kidney cancer	0.000373	0.0021	CcSEcCtD
Torasemide—Hypotension—Everolimus—kidney cancer	0.000373	0.0021	CcSEcCtD
Torasemide—Cough—Sorafenib—kidney cancer	0.00037	0.00209	CcSEcCtD
Torasemide—Rectal haemorrhage—Doxorubicin—kidney cancer	0.000367	0.00207	CcSEcCtD
Torasemide—Diarrhoea—Temsirolimus—kidney cancer	0.000367	0.00207	CcSEcCtD
Torasemide—Leukopenia—Sunitinib—kidney cancer	0.000365	0.00206	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Everolimus—kidney cancer	0.000363	0.00205	CcSEcCtD
Torasemide—Asthenia—Pazopanib—kidney cancer	0.000362	0.00204	CcSEcCtD
Torasemide—Arthralgia—Sorafenib—kidney cancer	0.000361	0.00204	CcSEcCtD
Torasemide—Myalgia—Sorafenib—kidney cancer	0.000361	0.00204	CcSEcCtD
Torasemide—Insomnia—Everolimus—kidney cancer	0.000361	0.00204	CcSEcCtD
Torasemide—Hyperuricaemia—Doxorubicin—kidney cancer	0.000358	0.00202	CcSEcCtD
Torasemide—Cough—Sunitinib—kidney cancer	0.000356	0.00201	CcSEcCtD
Torasemide—Erythema multiforme—Gemcitabine—kidney cancer	0.000356	0.00201	CcSEcCtD
Torasemide—Hyperglycaemia—Paclitaxel—kidney cancer	0.000355	0.002	CcSEcCtD
Torasemide—Dizziness—Temsirolimus—kidney cancer	0.000354	0.002	CcSEcCtD
Torasemide—Dyspepsia—Everolimus—kidney cancer	0.000351	0.00198	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.00035	0.00198	CcSEcCtD
Torasemide—Insomnia—Erlotinib—kidney cancer	0.000348	0.00196	CcSEcCtD
Torasemide—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.000348	0.00196	CcSEcCtD
Torasemide—Arthralgia—Sunitinib—kidney cancer	0.000347	0.00196	CcSEcCtD
Torasemide—Chest pain—Sunitinib—kidney cancer	0.000347	0.00196	CcSEcCtD
Torasemide—Myalgia—Sunitinib—kidney cancer	0.000347	0.00196	CcSEcCtD
Torasemide—Dehydration—Capecitabine—kidney cancer	0.000347	0.00196	CcSEcCtD
Torasemide—Leukopenia—Dactinomycin—kidney cancer	0.000346	0.00195	CcSEcCtD
Torasemide—Diarrhoea—Pazopanib—kidney cancer	0.000345	0.00195	CcSEcCtD
Torasemide—Constipation—Vinblastine—kidney cancer	0.000342	0.00193	CcSEcCtD
Torasemide—Pain—Vinblastine—kidney cancer	0.000342	0.00193	CcSEcCtD
Torasemide—Pain—Everolimus—kidney cancer	0.000341	0.00192	CcSEcCtD
Torasemide—Constipation—Everolimus—kidney cancer	0.000341	0.00192	CcSEcCtD
Torasemide—Vomiting—Temsirolimus—kidney cancer	0.000341	0.00192	CcSEcCtD
Torasemide—Shock—Sorafenib—kidney cancer	0.00034	0.00192	CcSEcCtD
Torasemide—Hypokalaemia—Capecitabine—kidney cancer	0.00034	0.00192	CcSEcCtD
Torasemide—Thrombocytopenia—Sorafenib—kidney cancer	0.000339	0.00191	CcSEcCtD
Torasemide—Dyspepsia—Erlotinib—kidney cancer	0.000339	0.00191	CcSEcCtD
Torasemide—Rash—Temsirolimus—kidney cancer	0.000338	0.00191	CcSEcCtD
Torasemide—Blood uric acid increased—Doxorubicin—kidney cancer	0.000338	0.00191	CcSEcCtD
Torasemide—Dermatitis—Temsirolimus—kidney cancer	0.000338	0.00191	CcSEcCtD
Torasemide—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.000336	0.0019	CcSEcCtD
Torasemide—Headache—Temsirolimus—kidney cancer	0.000336	0.00189	CcSEcCtD
Torasemide—Dizziness—Pazopanib—kidney cancer	0.000334	0.00188	CcSEcCtD
Torasemide—Oedema—Sunitinib—kidney cancer	0.000333	0.00188	CcSEcCtD
Torasemide—Ventricular tachycardia—Doxorubicin—kidney cancer	0.000332	0.00187	CcSEcCtD
Torasemide—Pain—Erlotinib—kidney cancer	0.000329	0.00186	CcSEcCtD
Torasemide—Constipation—Erlotinib—kidney cancer	0.000329	0.00186	CcSEcCtD
Torasemide—Myalgia—Dactinomycin—kidney cancer	0.000329	0.00186	CcSEcCtD
Torasemide—Shock—Sunitinib—kidney cancer	0.000328	0.00185	CcSEcCtD
Torasemide—Thrombocytopenia—Sunitinib—kidney cancer	0.000326	0.00184	CcSEcCtD
Torasemide—Vomiting—Pazopanib—kidney cancer	0.000321	0.00181	CcSEcCtD
Torasemide—Rash—Pazopanib—kidney cancer	0.000318	0.0018	CcSEcCtD
Torasemide—Nausea—Temsirolimus—kidney cancer	0.000318	0.0018	CcSEcCtD
Torasemide—Dermatitis—Pazopanib—kidney cancer	0.000318	0.0018	CcSEcCtD
Torasemide—Haemoglobin—Paclitaxel—kidney cancer	0.000316	0.00179	CcSEcCtD
Torasemide—Headache—Pazopanib—kidney cancer	0.000316	0.00179	CcSEcCtD
Torasemide—Rhinitis—Paclitaxel—kidney cancer	0.000316	0.00178	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000315	0.00178	CcSEcCtD
Torasemide—Oedema—Dactinomycin—kidney cancer	0.000315	0.00178	CcSEcCtD
Torasemide—Haemorrhage—Paclitaxel—kidney cancer	0.000315	0.00178	CcSEcCtD
Torasemide—Leukopenia—Vincristine—kidney cancer	0.000309	0.00174	CcSEcCtD
Torasemide—Thrombocytopenia—Dactinomycin—kidney cancer	0.000309	0.00174	CcSEcCtD
Torasemide—Dyspepsia—Sorafenib—kidney cancer	0.000305	0.00172	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000303	0.00171	CcSEcCtD
Torasemide—Insomnia—Sunitinib—kidney cancer	0.000301	0.0017	CcSEcCtD
Torasemide—Nausea—Pazopanib—kidney cancer	0.0003	0.00169	CcSEcCtD
Torasemide—Erythema multiforme—Paclitaxel—kidney cancer	0.000298	0.00168	CcSEcCtD
Torasemide—Pain—Sorafenib—kidney cancer	0.000296	0.00167	CcSEcCtD
Torasemide—Constipation—Sorafenib—kidney cancer	0.000296	0.00167	CcSEcCtD
Torasemide—Myalgia—Vincristine—kidney cancer	0.000294	0.00166	CcSEcCtD
Torasemide—Dyspepsia—Sunitinib—kidney cancer	0.000293	0.00165	CcSEcCtD
Torasemide—Leukopenia—Gemcitabine—kidney cancer	0.000293	0.00165	CcSEcCtD
Torasemide—Hyperglycaemia—Capecitabine—kidney cancer	0.000291	0.00164	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000287	0.00162	CcSEcCtD
Torasemide—Asthenia—Vinblastine—kidney cancer	0.000287	0.00162	CcSEcCtD
Torasemide—Asthenia—Everolimus—kidney cancer	0.000286	0.00161	CcSEcCtD
Torasemide—Cough—Gemcitabine—kidney cancer	0.000286	0.00161	CcSEcCtD
Torasemide—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000285	0.00161	CcSEcCtD
Torasemide—Constipation—Sunitinib—kidney cancer	0.000285	0.00161	CcSEcCtD
Torasemide—Pain—Sunitinib—kidney cancer	0.000285	0.00161	CcSEcCtD
Torasemide—Oedema—Vincristine—kidney cancer	0.000282	0.00159	CcSEcCtD
Torasemide—Chest pain—Gemcitabine—kidney cancer	0.000279	0.00157	CcSEcCtD
Torasemide—Myalgia—Gemcitabine—kidney cancer	0.000279	0.00157	CcSEcCtD
Torasemide—Arthralgia—Gemcitabine—kidney cancer	0.000279	0.00157	CcSEcCtD
Torasemide—Asthenia—Erlotinib—kidney cancer	0.000276	0.00156	CcSEcCtD
Torasemide—Thrombocytopenia—Vincristine—kidney cancer	0.000276	0.00156	CcSEcCtD
Torasemide—Diarrhoea—Vinblastine—kidney cancer	0.000274	0.00155	CcSEcCtD
Torasemide—Diarrhoea—Everolimus—kidney cancer	0.000273	0.00154	CcSEcCtD
Torasemide—Pain—Dactinomycin—kidney cancer	0.00027	0.00152	CcSEcCtD
Torasemide—Tension—Paclitaxel—kidney cancer	0.000269	0.00152	CcSEcCtD
Torasemide—Oedema—Gemcitabine—kidney cancer	0.000267	0.00151	CcSEcCtD
Torasemide—Nervousness—Paclitaxel—kidney cancer	0.000266	0.0015	CcSEcCtD
Torasemide—Dizziness—Vinblastine—kidney cancer	0.000265	0.00149	CcSEcCtD
Torasemide—Dizziness—Everolimus—kidney cancer	0.000264	0.00149	CcSEcCtD
Torasemide—Diarrhoea—Erlotinib—kidney cancer	0.000263	0.00149	CcSEcCtD
Torasemide—Hypotension—Vincristine—kidney cancer	0.000263	0.00149	CcSEcCtD
Torasemide—Thrombocytopenia—Gemcitabine—kidney cancer	0.000262	0.00148	CcSEcCtD
Torasemide—Haemoglobin—Capecitabine—kidney cancer	0.00026	0.00147	CcSEcCtD
Torasemide—Rhinitis—Capecitabine—kidney cancer	0.000259	0.00146	CcSEcCtD
Torasemide—Haemorrhage—Capecitabine—kidney cancer	0.000258	0.00146	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000257	0.00145	CcSEcCtD
Torasemide—Insomnia—Vincristine—kidney cancer	0.000255	0.00144	CcSEcCtD
Torasemide—Vomiting—Vinblastine—kidney cancer	0.000254	0.00144	CcSEcCtD
Torasemide—Dizziness—Erlotinib—kidney cancer	0.000254	0.00144	CcSEcCtD
Torasemide—Vomiting—Everolimus—kidney cancer	0.000253	0.00143	CcSEcCtD
Torasemide—Rash—Everolimus—kidney cancer	0.000251	0.00142	CcSEcCtD
Torasemide—Dermatitis—Everolimus—kidney cancer	0.000251	0.00142	CcSEcCtD
Torasemide—Headache—Vinblastine—kidney cancer	0.000251	0.00141	CcSEcCtD
Torasemide—Angioedema—Paclitaxel—kidney cancer	0.00025	0.00141	CcSEcCtD
Torasemide—Headache—Everolimus—kidney cancer	0.00025	0.00141	CcSEcCtD
Torasemide—Hypotension—Gemcitabine—kidney cancer	0.00025	0.00141	CcSEcCtD
Torasemide—Asthenia—Sorafenib—kidney cancer	0.000248	0.0014	CcSEcCtD
Torasemide—Syncope—Paclitaxel—kidney cancer	0.000246	0.00139	CcSEcCtD
Torasemide—Leukopenia—Paclitaxel—kidney cancer	0.000245	0.00138	CcSEcCtD
Torasemide—Vomiting—Erlotinib—kidney cancer	0.000245	0.00138	CcSEcCtD
Torasemide—Erythema multiforme—Capecitabine—kidney cancer	0.000244	0.00138	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000243	0.00137	CcSEcCtD
Torasemide—Rash—Erlotinib—kidney cancer	0.000243	0.00137	CcSEcCtD
Torasemide—Dermatitis—Erlotinib—kidney cancer	0.000242	0.00137	CcSEcCtD
Torasemide—Hyponatraemia—Doxorubicin—kidney cancer	0.000242	0.00136	CcSEcCtD
Torasemide—Insomnia—Gemcitabine—kidney cancer	0.000242	0.00136	CcSEcCtD
Torasemide—Headache—Erlotinib—kidney cancer	0.000241	0.00136	CcSEcCtD
Torasemide—Loss of consciousness—Paclitaxel—kidney cancer	0.000241	0.00136	CcSEcCtD
Torasemide—Pain—Vincristine—kidney cancer	0.000241	0.00136	CcSEcCtD
Torasemide—Constipation—Vincristine—kidney cancer	0.000241	0.00136	CcSEcCtD
Torasemide—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000241	0.00136	CcSEcCtD
Torasemide—Cough—Paclitaxel—kidney cancer	0.000239	0.00135	CcSEcCtD
Torasemide—Asthenia—Sunitinib—kidney cancer	0.000239	0.00135	CcSEcCtD
Torasemide—Nausea—Vinblastine—kidney cancer	0.000238	0.00134	CcSEcCtD
Torasemide—Nausea—Everolimus—kidney cancer	0.000237	0.00134	CcSEcCtD
Torasemide—Diarrhoea—Sorafenib—kidney cancer	0.000237	0.00134	CcSEcCtD
Torasemide—Myalgia—Paclitaxel—kidney cancer	0.000233	0.00132	CcSEcCtD
Torasemide—Chest pain—Paclitaxel—kidney cancer	0.000233	0.00132	CcSEcCtD
Torasemide—Arthralgia—Paclitaxel—kidney cancer	0.000233	0.00132	CcSEcCtD
Torasemide—Dizziness—Sorafenib—kidney cancer	0.000229	0.00129	CcSEcCtD
Torasemide—Pain—Gemcitabine—kidney cancer	0.000228	0.00129	CcSEcCtD
Torasemide—Constipation—Gemcitabine—kidney cancer	0.000228	0.00129	CcSEcCtD
Torasemide—Nausea—Erlotinib—kidney cancer	0.000228	0.00129	CcSEcCtD
Torasemide—Diarrhoea—Sunitinib—kidney cancer	0.000228	0.00129	CcSEcCtD
Torasemide—Asthenia—Dactinomycin—kidney cancer	0.000226	0.00128	CcSEcCtD
Torasemide—Dehydration—Doxorubicin—kidney cancer	0.000224	0.00126	CcSEcCtD
Torasemide—Oedema—Paclitaxel—kidney cancer	0.000224	0.00126	CcSEcCtD
Torasemide—Dizziness—Sunitinib—kidney cancer	0.00022	0.00124	CcSEcCtD
Torasemide—Shock—Paclitaxel—kidney cancer	0.00022	0.00124	CcSEcCtD
Torasemide—Vomiting—Sorafenib—kidney cancer	0.00022	0.00124	CcSEcCtD
Torasemide—Hypokalaemia—Doxorubicin—kidney cancer	0.000219	0.00124	CcSEcCtD
Torasemide—Thrombocytopenia—Paclitaxel—kidney cancer	0.000219	0.00124	CcSEcCtD
Torasemide—Rash—Sorafenib—kidney cancer	0.000218	0.00123	CcSEcCtD
Torasemide—Dermatitis—Sorafenib—kidney cancer	0.000218	0.00123	CcSEcCtD
Torasemide—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000217	0.00122	CcSEcCtD
Torasemide—Headache—Sorafenib—kidney cancer	0.000217	0.00122	CcSEcCtD
Torasemide—Diarrhoea—Dactinomycin—kidney cancer	0.000216	0.00122	CcSEcCtD
Torasemide—Vomiting—Sunitinib—kidney cancer	0.000212	0.00119	CcSEcCtD
Torasemide—Rash—Sunitinib—kidney cancer	0.00021	0.00118	CcSEcCtD
Torasemide—Dermatitis—Sunitinib—kidney cancer	0.00021	0.00118	CcSEcCtD
Torasemide—Hypotension—Paclitaxel—kidney cancer	0.000209	0.00118	CcSEcCtD
Torasemide—Headache—Sunitinib—kidney cancer	0.000209	0.00118	CcSEcCtD
Torasemide—Nausea—Sorafenib—kidney cancer	0.000206	0.00116	CcSEcCtD
Torasemide—Pancreatitis—Doxorubicin—kidney cancer	0.000204	0.00115	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000204	0.00115	CcSEcCtD
Torasemide—Insomnia—Paclitaxel—kidney cancer	0.000202	0.00114	CcSEcCtD
Torasemide—Asthenia—Vincristine—kidney cancer	0.000202	0.00114	CcSEcCtD
Torasemide—Syncope—Capecitabine—kidney cancer	0.000202	0.00114	CcSEcCtD
Torasemide—Leukopenia—Capecitabine—kidney cancer	0.000201	0.00114	CcSEcCtD
Torasemide—Vomiting—Dactinomycin—kidney cancer	0.0002	0.00113	CcSEcCtD
Torasemide—Rash—Dactinomycin—kidney cancer	0.000199	0.00112	CcSEcCtD
Torasemide—Nausea—Sunitinib—kidney cancer	0.000198	0.00112	CcSEcCtD
Torasemide—Loss of consciousness—Capecitabine—kidney cancer	0.000198	0.00112	CcSEcCtD
Torasemide—Dyspepsia—Paclitaxel—kidney cancer	0.000197	0.00111	CcSEcCtD
Torasemide—Cough—Capecitabine—kidney cancer	0.000196	0.00111	CcSEcCtD
Torasemide—Diarrhoea—Vincristine—kidney cancer	0.000193	0.00109	CcSEcCtD
Torasemide—Asthenia—Gemcitabine—kidney cancer	0.000192	0.00108	CcSEcCtD
Torasemide—Chest pain—Capecitabine—kidney cancer	0.000192	0.00108	CcSEcCtD
Torasemide—Myalgia—Capecitabine—kidney cancer	0.000192	0.00108	CcSEcCtD
Torasemide—Arthralgia—Capecitabine—kidney cancer	0.000192	0.00108	CcSEcCtD
Torasemide—Constipation—Paclitaxel—kidney cancer	0.000191	0.00108	CcSEcCtD
Torasemide—Pain—Paclitaxel—kidney cancer	0.000191	0.00108	CcSEcCtD
Torasemide—Hyperglycaemia—Doxorubicin—kidney cancer	0.000188	0.00106	CcSEcCtD
Torasemide—Nausea—Dactinomycin—kidney cancer	0.000187	0.00106	CcSEcCtD
Torasemide—Dizziness—Vincristine—kidney cancer	0.000186	0.00105	CcSEcCtD
Torasemide—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000184	0.00104	CcSEcCtD
Torasemide—Oedema—Capecitabine—kidney cancer	0.000184	0.00104	CcSEcCtD
Torasemide—Diarrhoea—Gemcitabine—kidney cancer	0.000183	0.00103	CcSEcCtD
Torasemide—Shock—Capecitabine—kidney cancer	0.000181	0.00102	CcSEcCtD
Torasemide—Thrombocytopenia—Capecitabine—kidney cancer	0.00018	0.00101	CcSEcCtD
Torasemide—Vomiting—Vincristine—kidney cancer	0.000179	0.00101	CcSEcCtD
Torasemide—Rash—Vincristine—kidney cancer	0.000178	0.001	CcSEcCtD
Torasemide—Dermatitis—Vincristine—kidney cancer	0.000177	0.001	CcSEcCtD
Torasemide—Headache—Vincristine—kidney cancer	0.000176	0.000996	CcSEcCtD
Torasemide—Hypotension—Capecitabine—kidney cancer	0.000172	0.000968	CcSEcCtD
Torasemide—Vomiting—Gemcitabine—kidney cancer	0.00017	0.000959	CcSEcCtD
Torasemide—Rash—Gemcitabine—kidney cancer	0.000168	0.000951	CcSEcCtD
Torasemide—Dermatitis—Gemcitabine—kidney cancer	0.000168	0.00095	CcSEcCtD
Torasemide—Haemoglobin—Doxorubicin—kidney cancer	0.000167	0.000945	CcSEcCtD
Torasemide—Headache—Gemcitabine—kidney cancer	0.000167	0.000945	CcSEcCtD
Torasemide—Nausea—Vincristine—kidney cancer	0.000167	0.000944	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000167	0.000944	CcSEcCtD
Torasemide—Rhinitis—Doxorubicin—kidney cancer	0.000167	0.000942	CcSEcCtD
Torasemide—Haemorrhage—Doxorubicin—kidney cancer	0.000167	0.00094	CcSEcCtD
Torasemide—Insomnia—Capecitabine—kidney cancer	0.000166	0.000937	CcSEcCtD
Torasemide—Dyspepsia—Capecitabine—kidney cancer	0.000162	0.000912	CcSEcCtD
Torasemide—Asthenia—Paclitaxel—kidney cancer	0.000161	0.000906	CcSEcCtD
Torasemide—Nausea—Gemcitabine—kidney cancer	0.000159	0.000896	CcSEcCtD
Torasemide—Erythema multiforme—Doxorubicin—kidney cancer	0.000157	0.000889	CcSEcCtD
Torasemide—Constipation—Capecitabine—kidney cancer	0.000157	0.000886	CcSEcCtD
Torasemide—Pain—Capecitabine—kidney cancer	0.000157	0.000886	CcSEcCtD
Torasemide—Diarrhoea—Paclitaxel—kidney cancer	0.000153	0.000864	CcSEcCtD
Torasemide—Dizziness—Paclitaxel—kidney cancer	0.000148	0.000835	CcSEcCtD
Torasemide—Tension—Doxorubicin—kidney cancer	0.000142	0.000803	CcSEcCtD
Torasemide—Vomiting—Paclitaxel—kidney cancer	0.000142	0.000803	CcSEcCtD
Torasemide—Rash—Paclitaxel—kidney cancer	0.000141	0.000796	CcSEcCtD
Torasemide—Dermatitis—Paclitaxel—kidney cancer	0.000141	0.000795	CcSEcCtD
Torasemide—Nervousness—Doxorubicin—kidney cancer	0.000141	0.000795	CcSEcCtD
Torasemide—Headache—Paclitaxel—kidney cancer	0.00014	0.000791	CcSEcCtD
Torasemide—Nausea—Paclitaxel—kidney cancer	0.000133	0.00075	CcSEcCtD
Torasemide—Asthenia—Capecitabine—kidney cancer	0.000132	0.000743	CcSEcCtD
Torasemide—Syncope—Doxorubicin—kidney cancer	0.00013	0.000734	CcSEcCtD
Torasemide—Leukopenia—Doxorubicin—kidney cancer	0.00013	0.000732	CcSEcCtD
Torasemide—Loss of consciousness—Doxorubicin—kidney cancer	0.000127	0.000719	CcSEcCtD
Torasemide—Cough—Doxorubicin—kidney cancer	0.000127	0.000714	CcSEcCtD
Torasemide—Diarrhoea—Capecitabine—kidney cancer	0.000126	0.000709	CcSEcCtD
Torasemide—Arthralgia—Doxorubicin—kidney cancer	0.000123	0.000697	CcSEcCtD
Torasemide—Chest pain—Doxorubicin—kidney cancer	0.000123	0.000697	CcSEcCtD
Torasemide—Myalgia—Doxorubicin—kidney cancer	0.000123	0.000697	CcSEcCtD
Torasemide—Dizziness—Capecitabine—kidney cancer	0.000121	0.000685	CcSEcCtD
Torasemide—Oedema—Doxorubicin—kidney cancer	0.000118	0.000668	CcSEcCtD
Torasemide—Vomiting—Capecitabine—kidney cancer	0.000117	0.000659	CcSEcCtD
Torasemide—Shock—Doxorubicin—kidney cancer	0.000116	0.000657	CcSEcCtD
Torasemide—Thrombocytopenia—Doxorubicin—kidney cancer	0.000116	0.000654	CcSEcCtD
Torasemide—Rash—Capecitabine—kidney cancer	0.000116	0.000653	CcSEcCtD
Torasemide—Dermatitis—Capecitabine—kidney cancer	0.000116	0.000653	CcSEcCtD
Torasemide—Headache—Capecitabine—kidney cancer	0.000115	0.000649	CcSEcCtD
Torasemide—Hypotension—Doxorubicin—kidney cancer	0.000111	0.000624	CcSEcCtD
Torasemide—Nausea—Capecitabine—kidney cancer	0.000109	0.000615	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000108	0.000608	CcSEcCtD
Torasemide—Insomnia—Doxorubicin—kidney cancer	0.000107	0.000604	CcSEcCtD
Torasemide—Dyspepsia—Doxorubicin—kidney cancer	0.000104	0.000588	CcSEcCtD
Torasemide—Constipation—Doxorubicin—kidney cancer	0.000101	0.000571	CcSEcCtD
Torasemide—Pain—Doxorubicin—kidney cancer	0.000101	0.000571	CcSEcCtD
Torasemide—Asthenia—Doxorubicin—kidney cancer	8.49e-05	0.000479	CcSEcCtD
Torasemide—Diarrhoea—Doxorubicin—kidney cancer	8.1e-05	0.000457	CcSEcCtD
Torasemide—Dizziness—Doxorubicin—kidney cancer	7.83e-05	0.000442	CcSEcCtD
Torasemide—Vomiting—Doxorubicin—kidney cancer	7.52e-05	0.000425	CcSEcCtD
Torasemide—Rash—Doxorubicin—kidney cancer	7.46e-05	0.000421	CcSEcCtD
Torasemide—Dermatitis—Doxorubicin—kidney cancer	7.45e-05	0.000421	CcSEcCtD
Torasemide—Headache—Doxorubicin—kidney cancer	7.41e-05	0.000418	CcSEcCtD
Torasemide—Nausea—Doxorubicin—kidney cancer	7.03e-05	0.000397	CcSEcCtD
Torasemide—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	4.37e-05	0.00642	CbGpPWpGaD
Torasemide—CYP2C9—Arachidonic acid metabolism—PTGS1—kidney cancer	4.37e-05	0.00642	CbGpPWpGaD
Torasemide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	4.17e-05	0.00612	CbGpPWpGaD
Torasemide—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	3.76e-05	0.00553	CbGpPWpGaD
Torasemide—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	3.75e-05	0.00551	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—ALDH1A1—kidney cancer	3.63e-05	0.00533	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—SOD2—kidney cancer	3.61e-05	0.0053	CbGpPWpGaD
Torasemide—CYP2C8—Arachidonic acid metabolism—CYP1A1—kidney cancer	3.46e-05	0.00508	CbGpPWpGaD
Torasemide—SLC12A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.38e-05	0.00496	CbGpPWpGaD
Torasemide—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	3.36e-05	0.00493	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—GSTT1—kidney cancer	3.3e-05	0.00485	CbGpPWpGaD
Torasemide—SLC12A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.26e-05	0.00479	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—ALDH1A1—kidney cancer	3.24e-05	0.00476	CbGpPWpGaD
Torasemide—PTGS1—Arachidonic acid metabolism—PTGS2—kidney cancer	3.19e-05	0.00468	CbGpPWpGaD
Torasemide—CYP2C19—Arachidonic acid metabolism—CYP1A1—kidney cancer	3.09e-05	0.00454	CbGpPWpGaD
Torasemide—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	3.06e-05	0.0045	CbGpPWpGaD
Torasemide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	2.99e-05	0.00439	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—ALDH1A1—kidney cancer	2.95e-05	0.00434	CbGpPWpGaD
Torasemide—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	2.95e-05	0.00433	CbGpPWpGaD
Torasemide—CYP2C9—Arachidonic acid metabolism—CYP1A1—kidney cancer	2.82e-05	0.00414	CbGpPWpGaD
Torasemide—PTGS1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.8e-05	0.00411	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	2.73e-05	0.00401	CbGpPWpGaD
Torasemide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	2.67e-05	0.00392	CbGpPWpGaD
Torasemide—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	2.64e-05	0.00387	CbGpPWpGaD
Torasemide—SLC12A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.57e-05	0.00378	CbGpPWpGaD
Torasemide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	2.43e-05	0.00357	CbGpPWpGaD
Torasemide—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	2.43e-05	0.00356	CbGpPWpGaD
Torasemide—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	2.4e-05	0.00353	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—GSTP1—kidney cancer	2.29e-05	0.00336	CbGpPWpGaD
Torasemide—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.23e-05	0.00327	CbGpPWpGaD
Torasemide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	2.16e-05	0.00318	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—GSTT1—kidney cancer	2.13e-05	0.00313	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—GSTM1—kidney cancer	2.1e-05	0.00309	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—RELA—kidney cancer	2.09e-05	0.00306	CbGpPWpGaD
Torasemide—CYP2C8—Arachidonic acid metabolism—PTGS2—kidney cancer	2.06e-05	0.00302	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—PTGS2—kidney cancer	2.03e-05	0.00298	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—PTGS1—kidney cancer	2e-05	0.00293	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—CYP1A1—kidney cancer	1.99e-05	0.00293	CbGpPWpGaD
Torasemide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	1.99e-05	0.00292	CbGpPWpGaD
Torasemide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	1.97e-05	0.0029	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—GSTT1—kidney cancer	1.9e-05	0.0028	CbGpPWpGaD
Torasemide—CYP2C19—Arachidonic acid metabolism—PTGS2—kidney cancer	1.84e-05	0.0027	CbGpPWpGaD
Torasemide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	1.82e-05	0.00266	CbGpPWpGaD
Torasemide—CYP2C8—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.81e-05	0.00265	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—PTGS1—kidney cancer	1.78e-05	0.00262	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	1.76e-05	0.00259	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—ACY1—kidney cancer	1.75e-05	0.00258	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—GSTT1—kidney cancer	1.74e-05	0.00255	CbGpPWpGaD
Torasemide—CYP2C9—Arachidonic acid metabolism—PTGS2—kidney cancer	1.68e-05	0.00246	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—PTGS1—kidney cancer	1.63e-05	0.00239	CbGpPWpGaD
Torasemide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.61e-05	0.00237	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	1.57e-05	0.00231	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.5e-05	0.0022	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PDHB—kidney cancer	1.49e-05	0.00219	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—POMC—kidney cancer	1.49e-05	0.00218	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—GSTP1—kidney cancer	1.48e-05	0.00217	CbGpPWpGaD
Torasemide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.47e-05	0.00216	CbGpPWpGaD
Torasemide—CYP2C8—Metapathway biotransformation—GSTP1—kidney cancer	1.46e-05	0.00214	CbGpPWpGaD
Torasemide—SLC12A1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.46e-05	0.00214	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	1.44e-05	0.00211	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CCBL1—kidney cancer	1.4e-05	0.00206	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—GSTM1—kidney cancer	1.36e-05	0.00199	CbGpPWpGaD
Torasemide—CYP2C8—Metapathway biotransformation—GSTM1—kidney cancer	1.34e-05	0.00197	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—GSTP1—kidney cancer	1.32e-05	0.00194	CbGpPWpGaD
Torasemide—CYP2C19—Metapathway biotransformation—GSTP1—kidney cancer	1.3e-05	0.00191	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—CYP1A1—kidney cancer	1.29e-05	0.00189	CbGpPWpGaD
Torasemide—CYP2C8—Metapathway biotransformation—CYP1A1—kidney cancer	1.27e-05	0.00187	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.27e-05	0.00186	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PPAT—kidney cancer	1.22e-05	0.00179	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GLIPR1—kidney cancer	1.22e-05	0.00179	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—GSTM1—kidney cancer	1.21e-05	0.00178	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—GSTP1—kidney cancer	1.2e-05	0.00177	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.2e-05	0.00176	CbGpPWpGaD
Torasemide—CYP2C19—Metapathway biotransformation—GSTM1—kidney cancer	1.2e-05	0.00176	CbGpPWpGaD
Torasemide—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	1.19e-05	0.00174	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—CYP1A1—kidney cancer	1.15e-05	0.00169	CbGpPWpGaD
Torasemide—CYP2C19—Metapathway biotransformation—CYP1A1—kidney cancer	1.13e-05	0.00166	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ACY1—kidney cancer	1.13e-05	0.00166	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—FH—kidney cancer	1.13e-05	0.00166	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—APRT—kidney cancer	1.13e-05	0.00166	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—GSTM1—kidney cancer	1.11e-05	0.00162	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.1e-05	0.00162	CbGpPWpGaD
Torasemide—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	1.09e-05	0.0016	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GPC3—kidney cancer	1.06e-05	0.00156	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	1.05e-05	0.00154	CbGpPWpGaD
Torasemide—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	1.03e-05	0.00152	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CA2—kidney cancer	1.03e-05	0.00152	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ACY1—kidney cancer	1.01e-05	0.00148	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—ALAD—kidney cancer	1.01e-05	0.00148	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—ST3GAL2—kidney cancer	9.83e-06	0.00144	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	9.66e-06	0.00142	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PDHB—kidney cancer	9.63e-06	0.00141	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—ALDH1A1—kidney cancer	9.61e-06	0.00141	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—POMC—kidney cancer	9.6e-06	0.00141	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ACY1—kidney cancer	9.22e-06	0.00135	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PGK1—kidney cancer	9.22e-06	0.00135	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—SLC5A3—kidney cancer	9.22e-06	0.00135	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CCBL1—kidney cancer	9.06e-06	0.00133	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—LDHB—kidney cancer	9.04e-06	0.00133	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	8.63e-06	0.00127	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PDHB—kidney cancer	8.6e-06	0.00126	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—POMC—kidney cancer	8.57e-06	0.00126	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	8.19e-06	0.0012	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CCBL1—kidney cancer	8.09e-06	0.00119	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	7.86e-06	0.00115	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PPAT—kidney cancer	7.85e-06	0.00115	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GLIPR1—kidney cancer	7.85e-06	0.00115	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PDHB—kidney cancer	7.84e-06	0.00115	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CA9—kidney cancer	7.84e-06	0.00115	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—POMC—kidney cancer	7.82e-06	0.00115	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	7.75e-06	0.00114	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	7.68e-06	0.00113	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.66e-06	0.00112	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CCBL1—kidney cancer	7.37e-06	0.00108	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	7.31e-06	0.00107	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—APRT—kidney cancer	7.3e-06	0.00107	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—FH—kidney cancer	7.3e-06	0.00107	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	7.14e-06	0.00105	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GLIPR1—kidney cancer	7.01e-06	0.00103	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PPAT—kidney cancer	7.01e-06	0.00103	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	6.92e-06	0.00102	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GPC3—kidney cancer	6.87e-06	0.00101	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	6.85e-06	0.00101	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CA2—kidney cancer	6.68e-06	0.00098	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	6.67e-06	0.000979	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CRABP1—kidney cancer	6.66e-06	0.000978	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—APRT—kidney cancer	6.52e-06	0.000957	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—FH—kidney cancer	6.52e-06	0.000957	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ALAD—kidney cancer	6.51e-06	0.000955	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PPAT—kidney cancer	6.39e-06	0.000938	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GLIPR1—kidney cancer	6.39e-06	0.000938	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	6.37e-06	0.000935	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ST3GAL2—kidney cancer	6.35e-06	0.000933	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	6.31e-06	0.000927	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	6.25e-06	0.000917	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ALDH1A1—kidney cancer	6.21e-06	0.000911	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—ITPR2—kidney cancer	6.19e-06	0.000909	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GPC3—kidney cancer	6.13e-06	0.0009	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CA2—kidney cancer	5.96e-06	0.000875	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PGK1—kidney cancer	5.95e-06	0.000874	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—SLC5A3—kidney cancer	5.95e-06	0.000874	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—FH—kidney cancer	5.94e-06	0.000872	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—APRT—kidney cancer	5.94e-06	0.000872	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—LDHB—kidney cancer	5.84e-06	0.000857	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ALAD—kidney cancer	5.81e-06	0.000853	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	5.81e-06	0.000853	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.71e-06	0.000838	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ST3GAL2—kidney cancer	5.67e-06	0.000832	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—ACHE—kidney cancer	5.65e-06	0.000829	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GSTT1—kidney cancer	5.65e-06	0.000829	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GPC3—kidney cancer	5.59e-06	0.00082	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ALDH1A1—kidney cancer	5.54e-06	0.000814	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CA2—kidney cancer	5.44e-06	0.000798	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—SCARB1—kidney cancer	5.35e-06	0.000785	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PGK1—kidney cancer	5.31e-06	0.00078	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—SLC5A3—kidney cancer	5.31e-06	0.00078	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ALAD—kidney cancer	5.3e-06	0.000778	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—LDHB—kidney cancer	5.21e-06	0.000765	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PSMD7—kidney cancer	5.19e-06	0.000762	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ST3GAL2—kidney cancer	5.17e-06	0.000759	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CA9—kidney cancer	5.06e-06	0.000743	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ALDH1A1—kidney cancer	5.05e-06	0.000742	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.95e-06	0.000726	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—BCHE—kidney cancer	4.92e-06	0.000722	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—SLC5A5—kidney cancer	4.86e-06	0.000714	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PGK1—kidney cancer	4.84e-06	0.000711	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—SLC5A3—kidney cancer	4.84e-06	0.000711	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—LDHB—kidney cancer	4.75e-06	0.000697	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—SLC2A1—kidney cancer	4.69e-06	0.000689	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.55e-06	0.000669	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CA9—kidney cancer	4.52e-06	0.000663	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.42e-06	0.000648	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CRABP1—kidney cancer	4.3e-06	0.000632	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CA9—kidney cancer	4.12e-06	0.000605	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.03e-06	0.000591	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ITPR2—kidney cancer	4e-06	0.000587	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.97e-06	0.000583	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GSTP1—kidney cancer	3.92e-06	0.000575	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CRABP1—kidney cancer	3.84e-06	0.000564	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—ABCB1—kidney cancer	3.71e-06	0.000544	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.69e-06	0.000541	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ACHE—kidney cancer	3.65e-06	0.000536	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GSTT1—kidney cancer	3.65e-06	0.000536	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GSTM1—kidney cancer	3.6e-06	0.000528	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ITPR2—kidney cancer	3.57e-06	0.000524	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CRABP1—kidney cancer	3.5e-06	0.000514	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—SCARB1—kidney cancer	3.45e-06	0.000507	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PTGS1—kidney cancer	3.42e-06	0.000502	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CYP1A1—kidney cancer	3.41e-06	0.000501	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PSMD7—kidney cancer	3.35e-06	0.000492	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.29e-06	0.000483	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ACHE—kidney cancer	3.26e-06	0.000478	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GSTT1—kidney cancer	3.26e-06	0.000478	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ITPR2—kidney cancer	3.26e-06	0.000478	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—BCHE—kidney cancer	3.18e-06	0.000467	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—SLC5A5—kidney cancer	3.14e-06	0.000461	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—SCARB1—kidney cancer	3.08e-06	0.000453	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PTGS1—kidney cancer	3.05e-06	0.000448	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—SLC2A1—kidney cancer	3.03e-06	0.000445	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3e-06	0.000441	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PSMD7—kidney cancer	2.99e-06	0.000439	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ACHE—kidney cancer	2.97e-06	0.000436	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GSTT1—kidney cancer	2.97e-06	0.000436	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.94e-06	0.000432	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—BCHE—kidney cancer	2.84e-06	0.000416	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—SCARB1—kidney cancer	2.81e-06	0.000413	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—SLC5A5—kidney cancer	2.8e-06	0.000411	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.8e-06	0.000411	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PTGS1—kidney cancer	2.78e-06	0.000408	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PSMD7—kidney cancer	2.73e-06	0.000401	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—SLC2A1—kidney cancer	2.71e-06	0.000397	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.63e-06	0.000385	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—BCHE—kidney cancer	2.59e-06	0.00038	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.57e-06	0.000377	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—SLC5A5—kidney cancer	2.56e-06	0.000375	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—POMC—kidney cancer	2.54e-06	0.000373	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GSTP1—kidney cancer	2.53e-06	0.000371	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—SLC2A1—kidney cancer	2.47e-06	0.000362	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.39e-06	0.000351	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ABCB1—kidney cancer	2.39e-06	0.000351	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GSTM1—kidney cancer	2.32e-06	0.000341	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.29e-06	0.000336	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GSTP1—kidney cancer	2.26e-06	0.000331	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CYP1A1—kidney cancer	2.2e-06	0.000323	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ABCB1—kidney cancer	2.14e-06	0.000314	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.09e-06	0.000307	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GSTM1—kidney cancer	2.07e-06	0.000305	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GSTP1—kidney cancer	2.06e-06	0.000302	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PTGS2—kidney cancer	2.03e-06	0.000298	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CYP1A1—kidney cancer	1.97e-06	0.000289	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ABCB1—kidney cancer	1.95e-06	0.000286	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GSTM1—kidney cancer	1.89e-06	0.000278	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.81e-06	0.000266	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.79e-06	0.000263	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PTEN—kidney cancer	1.77e-06	0.00026	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—POMC—kidney cancer	1.64e-06	0.000241	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.62e-06	0.000237	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.47e-06	0.000216	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—POMC—kidney cancer	1.47e-06	0.000215	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—POMC—kidney cancer	1.34e-06	0.000196	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PTGS2—kidney cancer	1.31e-06	0.000192	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PIK3CA—kidney cancer	1.25e-06	0.000183	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PTGS2—kidney cancer	1.17e-06	0.000172	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PTEN—kidney cancer	1.14e-06	0.000168	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PTGS2—kidney cancer	1.07e-06	0.000157	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PTEN—kidney cancer	1.02e-06	0.00015	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PTEN—kidney cancer	9.3e-07	0.000137	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PIK3CA—kidney cancer	8.06e-07	0.000118	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PIK3CA—kidney cancer	7.19e-07	0.000106	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PIK3CA—kidney cancer	6.56e-07	9.63e-05	CbGpPWpGaD
